TY  - GEN
AU  - Ferreira Filho,A F
AU  - Di Leo,A
AU  - Paesmans,M
AU  - Beauduin,M
AU  - Vindevoghel,A
AU  - Michel,J
AU  - Focan,C
AU  - Awada,A
AU  - Cardoso,F
AU  - Dolci,S
AU  - Bartholomeus,S
AU  - Piccart,M J
TI  - The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
SN  - 0923-7534
PY  - 2002///1104
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Belgium
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Feasibility Studies
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Lymph Nodes
KW  - pathology
KW  - Lymphatic Metastasis
KW  - Methotrexate
KW  - Middle Aged
KW  - Postmenopause
KW  - Premenopause
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1093/annonc/mdf051
ER  -